Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Non-Small Cell Lung Cancer (NSCLC) Market From 2025 To 2029?

The market size of non-small cell lung cancer (nsclc) has experienced rapid expansion in recent years. It is set to increase from $20.1 billion in 2024 to $22.14 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.1%. The growth observed in the historical period is a product of advancements in immunotherapy, genomic profiling, and precision medicine, the extension of clinical trials, as well as initiatives aimed at smoking cessation.

The market size for non-small cell lung cancer (nsclc) is anticipated to experience a significant increase in the coming years. The value is predicted to reach$32.88 billion” by 2029, with a compound annual growth rate (CAGR) of 10.4%. The surge during the forecast period can be associated with the development of new combination therapies, the use of artificial intelligence (AI), advancements in personalized vaccines, international research collaborations, and patient-focused care. The forecast period will also witness major trends like the incorporation of telemedicine in the field of oncology, adoption of liquid biopsy technologies, progress in diagnostic technologies, a surge in minimally invasive surgery methods, and the usage of immune checkpoint inhibitors.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13232&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Non-Small Cell Lung Cancer (NSCLC) Market?

The growing trend of tobacco usage is predicted to drive the expansion of the non-small cell lung cancer (NSCLC) market. When individuals utilise tobacco products through habits such as smoking, chewing, or snuffing, nicotine and several other chemicals are introduced into the body. This tobacco smoke is laden with carcinogens that can harm the deoxyribonucleic acid (DNA) found in lung cells, causing mutations and uncontrolled proliferation of cancerous cells, including those of non-small-cell lung cancer (NSCLC). For example, the 2024 National Youth Tobacco Survey released in October 2024 by the US Food and Drug Administration (USFDA), a US federal agency, reported that 1.1% of all students (roughly 2.25 million) were using tobacco products currently. Furthermore, 10.1% of high school students (around 1.58 million) and 5.4% of middle school students (roughly 640,000) were also current tobacco users. In addition, about 760,000 students (or 2.8%) reported current use of any combustible tobacco product, and approximately 840,000 (or 3.0%) admitted to using multiple tobacco products. Hence, this uptrend in tobacco consumption is propelling the non-small cell lung cancer (NSCLC) market’s growth.

Which Primary Segments of the Non-Small Cell Lung Cancer (NSCLC) Market Are Driving Growth and Industry Transformations?

The non-small cell lung cancer (nsclc)market covered in this report is segmented –

1) By Type: Squamous Cell Carcinoma; Large Cell Carcinoma; Adenocarcinoma; Other Types

2) By Therapy: Radiotherapy; Laserthearpy; Photodynamic Therapy (PDT); Other Therapies

3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Other Distribution Channels

Subsegments:

1) By Squamous Cell Carcinoma: Keratinizing Squamous Cell Carcinoma; Non-Keratinizing Squamous Cell Carcinoma

2) By Large Cell Carcinoma: Undifferentiated Large Cell Carcinoma; Large Cell Neuroendocrine Carcinoma

3) By Adenocarcinoma: Invasive Adenocarcinoma; Bronchioloalveolar Carcinoma

4) By Other Types: Mixed Cell Type Carcinoma; Sarcomatoid Carcinoma

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13232&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Non-Small Cell Lung Cancer (NSCLC) Market?# Market?

North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (NSCLC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Non-Small Cell Lung Cancer (NSCLC) Market?

Top firms in the non-small cell lung cancer (NSCLC) market are investing in the development of various treatments, including monotherapy options, to gain a competitive advantage. Monotherapy involves the use of a single drug or therapeutic approach for treating a disease or condition, circumventing the need for multiple interventional methods. For example, in June 2022, the Switzerland-based pharmaceutical corporation Novartis AG received endorsement from the Belgium-based governing entity, the European Commission (EC), for the usage of Tabrecta (capmatinib) in treating adult patients suffering from advanced NSCLC with METex14 skipping. This provides innovative targeted therapy for NSCLC patients in Europe with advanced stages of the disease and METex14 skipping mutations, following prior treatment. It currently stands as the more prevalent targeted treatment for advanced NSCLC caused by METex14 skipping mutations.

View the full report here:

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

What Parameters Are Used to Define the Non-Small Cell Lung Cancer (NSCLC) Market?

Non-small cell lung cancer (NSCLC) is a type of epithelial lung cancer that develops in the tissues of the lungs and is characterized by the abnormal growth of cells. It is primarily caused by long-term smoking, genetic mutations, air pollution, and secondhand smoke.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13232

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model